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Abstract 
 
SYNTHESIS OF MULTIFUNCTIONAL NANOPARTICLES FOR THE POTENTIAL USE IN 
RADIATION THERAPY TREATMENT AND IMAGING MODALITIES 
 
 
By Gabrielle P. Seymore, B.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University. 
 
 
Virginia Commonwealth University, 2020. 
 
 
Major Director: Jessika V. Rojas, Assistant Professor, Department of Mechanical and Nuclear 
Engineering 
 
The purpose of this work was to synthesize nanoparticles composed of high atomic number 
elements and semiconductor material in a core/shell structure for the potential to be used as 
enhancers for radiotherapy as well as luminescence imaging platforms. Additionally, to quantify 
their role in free radical production after exposure to ionizing radiation through chemical routes. 
Spherical gold nanoparticles were synthesized via a citrate stabilizer method. Two sizes of 12nm 
and 25 nm gold spheres were used as the cores for the europium-doped gadolinium vanadate 
flower-shaped shell. The production of 7-hydroxycoumarin-3-carboxylic acid in an aqueous 
environment upon kV irradiation of its precursor, coumarin-3-carboxylic acid, was assessed and 
used as a fluorescence detector for hydroxyl radicals. The quantification of excess or moderation 
of hydroxyl radicals in the presence of the nanomaterial as compared to a control sample can 
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indicate the potential for increased DNA damage for purposes such as tumor control. This work 
indicates the potential for physical and chemical enhancement in the presence of nanomaterials. 
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I. Introduction 
 
Radiation Therapy and Limitations 
Radiation therapy is used in the treatment of approximately 50% of all cancer patients, both 
as a primary or adjuvant treatment avenue[1]. It has various roles in the care process for each 
individual patient ranging from pre and post-surgical radiation, concomitant chemotherapy, total 
body irradiation in preparation for bone marrow transplant, palliation, and much more.  Due to 
the steady prevalence of cancer incidence and the successes of radiation oncology in the past, the 
field has advanced in recent years due to new modalities and delivery techniques.  However, 
despite recent advancements in all aspects of the radiotherapy process, radiation still cannot 
discriminate between healthy and diseased tissues, therefore creating limitations of its 
success[2].  
Standard radiation therapy delivers ionizing radiation with an external megavoltage beam to 
a specified site of the body that is believed to contain cancerous cells via a linear accelerator 
(“linac”). Due to the traversing of the beam through skin and associated normal tissue, all objects 
within the beam path can be affected by the treatment. Megavoltage photon beams generated via 
linac have an associated skin-sparing effect with higher energies and can deliver maximum 
achievable dose to deep-seated tumors with less dermatitis and undesirable skin effects. While 
energy improvements, multi-leaf collimators (MLCs), and intensity-modulated radiation therapy 
(IMRT) have contributed to conformance to tumor volumes and improved targeting, many 
patients still experience normal tissue toxicity. Normal tissue toxicity can lead to various serious 
and uncomfortable side effect for patients dependent upon if the affected tissue is acute or late 
responding. These may include nausea, vomiting, diarrhea, pain, pneumonitis, chronic fibrosis, 
and more[3]. Additionally, tendencies are present to be conservative with dose prescriptions due 
to the proximity of critical structures and organs at risk (OAR) which can influence the clinical 
outcome for the patient[4].  
 
Nanotechnology in medicine  
Nanoparticles have been explored for many applications in medicine including drug delivery, 
hyperthermia, diagnosis, and imaging[5]. Nanotechnology is also one proposed solution to 
concentrating damage to cancerous cells while sparing normal tissue, by taking advantage of the 
9 
 
therapeutic window and inducing different responses between healthy and diseased tissues for 
clinical advantage[3]. The theory proposes introducing inorganic material into the body to 
interact with the ionizing radiation being delivered in order to “sensitize” the spatial locations 
where the nanomaterial is present. Therefore, this may contribute to achieving the clinical goal 
without escalating the dose and risking the critical structures and normal tissue in proximity. 
These materials have also been referred to in the literature as nano-radio-enhancers (NRE) to 
distinguish them from radiosensitizing drugs that inhibit DNA repair, but effectively cover the 
same subject matter[5]. In order to investigate the success and increased efficiency of this 
proposed treatment, the interactions of the nanomaterial with the ionizing radiation as well as the 
interactions of the nanomaterial with the body itself must be considered. Dose enhancement has 
been investigated by multiple research groups over the years due to the lack of understanding of 
the mechanisms for enhancement and discrepancies in predictive models for dose deposition and 
experimental results[1].  
 
Nanomaterial influence on the principles of radiotherapy  
It is first imperative to understand the basis of radiotherapy before examining the effect 
nanomaterial could have on these mechanisms. The principles of radiation therapy are based on 
the 5 R’s of radiobiology: repair, reoxygenation, redistribution, repopulation, and 
radiosensitivity. The presence of nanomaterial contributes to these pillars and influences their 
role in effective cancer treatment. Cui et al. review and summarize each of these R’s and analyze 
the nanomaterial impact of them[1]. 
1) Repair: DNA damage is the goal and result of traditional radiotherapy, and is sought to be 
amplified in the presence of nanoparticles. Not only is the physical damage effective, but 
also inhibiting or disrupting the intrinsic repair mechanisms of the cells could lead to 
increased cell death. Reactive Oxygen Species (ROS) scavenging is a repair pathway that 
attempts to remove those generated radicals post-irradiation, however cells in oxidative 
stress have limited scavenging capabilities which has been demonstrated in the presence 
of silver nanoparticles (AgNP).  
2) Reoxygenation: Oxygen is considered radiotherapy’s greatest natural radiosensitizer. 
While many creative tools have been utilized to reduce hypoxia, including specific 
chemotherapy drugs and fractionation schemes capitalizing on reoxygenation after 
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treatment, there is little evidence that demonstrates nanomaterial reoxygenates tumor 
sites. The oxidative state of the tumor during irradiation influences the effective 
radiosensitization by the nanomaterial. Consequently, nanomaterial appears to perform 
best under oxia, or normal oxygen levels of the cells.  
3) Redistribution: The phases of the cell cycle all have associated radiosensitivity. While it 
would seem advantageous to redistribute tumor cells into the most sensitive phases G2/M 
for treatment, conflicting evidence exists to support if nanomaterial affects this 
redistribution. Another method pertaining to redistribution is the use of cell cycle 
checkpoints. Checkpoints exist between the cell phases to screen and repair abnormal 
cells if these checkpoints are damaged or down-regulated then cell death could occur. 
Cell cycle synchronization has been demonstrated by multiple groups, although more in 
vivo studies are needed to confirm this concept. 
4) Repopulation: Repopulation refers to the proliferation of cells, healthy and diseased, after 
irradiation. While it is advantageous for affected normal tissue of radiotherapy to 
proliferate and replace itself, repopulation is also responsible for maintained tumor 
presence or growth. Prevention of repopulation includes halting angiogenesis and 
production of factors such as vascular endothelial growth factor (VEGF). When 
considering the use of nanomaterial, repopulation effects will change the local 
concentrations of nanoparticles due to the evolving ratios and excretion over time. 
Therefore special dosing considerations and fractionation schemes must be considered 
based on the specific proliferation time of the tumor site involved.  
5) Radiosensitization: This principle of radiobiology refers to the intrinsic radiosensitivity of 
cells. Due to heterogeneous mixtures of cells within tumor volumes, this cannot be solely 
defined by one value. It is essential to identify that nanomaterial as radiosensitizers refer 
to increased dose deposition locally, not aiming to modify the inherent nature of the cell 
itself. Survival fraction is often the measure of radiosensitivity. While decreased survival 
fractions have been observed in the presence of nanomaterial, no correlation has been 
demonstrated between nanomaterial and intrinsic radiosensitivity. Additionally, 
radiosensitizers have been considered for radioresistant tumors specifically to enhance 
the treatment effectively. 
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Nanomaterial influence on photon interactions and free radical production 
To further understand how nanomaterial interacts with the body and ionizing radiation, 
photon interaction mechanisms with matter must also be examined. Three main interactions of 
radiation with matter exist in radiation oncology. This work will primarily focus on photon 
interactions relevant to this research. Photoelectric effect, Compton scatter, and pair production 
are the primary photon interactions relevant to radiation therapy. While Compton scatter 
dominates for most of the megavoltage range, pair production is possible once the threshold of 
1.022 MeV is surpassed. The photoelectric cross-section (ɑ) increases proportionally with (Z/E)3, 
specifically dominating energies up to 500 keV. Therefore in the presence of high atomic 
number materials, energy can be transferred to the medium more effectively than water due to 
the photoelectrons ejected from the interaction of the photon with the inner electron shells[5] [6]. 
The de-excitation of the atom cannot be ignored when considering the spatial information of 
energy transfer. Fluorescence due to the differences in the incident photon energy and shell 
binding energy is a mode of de-excitation as well as Auger electrons. While Auger electrons 
have a shorter range and will most likely deposit their energy locally, fluorescence photons can 
travel larger distances based on their energy and therefore deposit energy and “dose” outside the 
region of interest. The result of this energy deposition by electrons is free radicals.  
These free radicals, often ROS generated from water, are deleterious to the DNA repair 
process post-irradiation and are thought to be the main species produced by metallic 
nanomaterial[7]. ROS include hydroxyl radicals, superoxide radicals, and hydrogen peroxide[8]. 
Hydroxyl radicals (HO·) are responsible for up to 50-70% of DNA damage in clinical photon 
radiotherapy[9][10]. G-values (mol/J) are quantitative measurement of (HO·) overproduction in 
the presence of nanomaterials and can be convenient in making comparisons between studies 
with varying parameters. The production of (HO·) can be accomplished by three main pathways. 
The first pathway involves the incident radiation having a primary interaction with the 
nanoparticle. Electrons ejected from this interaction can interact with surrounding water and 
create (HO·) as a radiolysis product. The second pathway removes the role of the nanoparticle, 
having the incident radiation interact directly with water molecules and produce (HO·). The third 
pathway is a continuation of the second pathway. However, these radiolysis products then 
secondarily interact with the nanoparticle to produce further reactive species[9].  
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Multifunctional nanoparticles 
The presence of foreign material in the body may have other advantages other than 
dosimetric radioenhancement, such as imaging. Computed tomography (CT), magnetic 
resonance imaging (MRI), positron-emission tomography (PET), single-photon emission 
tomography computed tomography (SPECT), and other imaging modalities are used in the 
radiotherapy process to visualize and delineate specific volumes. Contrast agents, such as 
gadolinium (Gd) or iodine (I) based, are often used in MRI and CT, respectively, to improve this 
delineation. The manipulation of the attenuation coefficients in associated tissues for CT and 
relaxation times in MRI allow for radiologists and technologists to more accurately read a 
patient’s anatomy. The presence of high atomic number material is advantageous in CT imaging 
due to its high density as compared to typical anatomy, but primarily to induce differential 
photoelectric absorption. Fluorescence imaging also takes advantage of the luminescence 
properties of contrast agents and materials to visualize their accumulation in specific tissues 
during procedures like surgery. Rare-earth metals are common doping agents for these materials 
that allow for a bright fluorescence signal with a tunable plasmon resonance energy[11]. These 
rare earth metals include elements such as europium and terbium for emission of red and green 
luminescence respectively under ultra-violet (UV) and near-infrared (NIR) excitation[12].  
 
II. Literature Review 
 
Previous Studies 
High atomic number material for dose enhancement has been investigated for the better part 
of a century. Gold nanoparticles have a historical role in this area of research due to their 
“relatively straightforward synthesis route, high stability in biocompatible solvents, low toxicity, 
and also good biodistribution and pharmacokinetics”[5]. Hainfeld at al. was the first group to 
demonstrate malignant tumor control in a pioneering in vivo study using high atomic number 
material when they injected 1.9nm gold nanoparticles into mice subjects with EMT-6 
subcutaneous mammary tumors and irradiated in the kilovoltage range to a dose of 26 Gy[13]. 
Hainfeld et al. further observed CT image contrast and improved long term survival in mice with 
a highly malignant brain tumor irradiated with 100 kVp x-rays to a dose of 35 Gy using 11nm 
AuNPs[5][14]. Al Zaki et al. was another group that investigated CT image contrast and 
13 
 
radioenhancement in mice with HT-1080 human fibrosarcoma tumors using 1.9nm AuNPs inside 
polymeric micelles at a concentration of 650mg AuNPs/kg.  A comparison was made to radiation 
treatment of mice without nanomaterial when treated with 6 Gy at 150 kVp. There they observed 
a 1.7 fold longer median survival time[5][15]. Other groups such as Miladi et al incorporated 
gadolinium chelates into their AuNP coatings to monitor biodistribution of the material using 
MRI and waiting until sufficient tumor uptake to treat 9L gliosarcoma brain tumor in mice via 
microbeam radiation therapy (MRT)[5][16]. An important distinction was made by McQuade et 
al. that exposed a fault in this theranostic approach to nanomaterial. The improved CT image 
contrast was achievable but at much higher concentrations of material injected than necessary to 
achieve radioenhancement, bringing about questions of biocompatibility and toxicity[5][17]. 
Therefore, MRI contrast material was investigated to achieve such image contrast at lower 
concentrations. These studies along with many others provided proof of concept; however, more 
relevant delivery parameters of radiation oncology such as megavoltage beams and increased 
dose rate needed to be investigated.  
Many of the aforementioned studies can be observed as using lower energies and dose rates 
than what is used in modern radiation therapy. This was to take advantage of the high 
photoelectric absorption cross-section and generation of secondary electrons from nanomaterial 
using kV X-rays. However, as observed in many studies, megavoltage beams combined with 
nanomaterial has demonstrated radioenhancement despite the primary interaction mechanism 
being Compton scattering. This interaction produces recoil electrons that can be of low energy 
but this event also reduces the photon energy and will likely proceed to lose more energy through 
larger angle scatter. The recoil electrons could induce a cascade of scattering events that are 
localized to the nanomaterial[5]. This effect could also be enhanced by flattening filter-free 
(FFF) beams in a clinical setting which still contain keV level photons for photoelectric effect 
and electron contamination which could directly ionize the atoms in the nanomaterial. Different 
treatment modalities such as proton therapy and heavy ion therapy have also been investigated 
for use with nanomaterial to explore radioenhancement. Kim et al. is responsible for the two 
main in vivo studies investigating the effect of proton irradiation on 1.9 and 14nm AuNPs as 
well as 13-15nm superparamagnetic iron oxide nanoparticles. However, high concentrations of 
the particles injected are noted here but the group did not observe toxicity in the mice with CT26 
mouse tumors treated with 41.7MeV spread-out Bragg peak (SOBP) beams[5][18][19]. Monte-
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Carlo simulations have also been conducted, such as by Abolfazli et al. using MCNPX code, to 
study dose enhancement in the presence of megavoltage radiation and gold nanoparticles. The 
simulation was performed with a cobalt-60 source and 6MV (separately) parallel photon beam 
irradiating a cubic volume with 30 or 50nm gold spherical nanoparticles. Dose enhancement was 
found with the larger nanoparticles, decreasing with distance from the central axis. Additionally, 
10- to 2000- fold increase in secondary electron production in the presence of AuNPs[20].  
 
ROS measurement  
While in vivo studies in cell lines can use survival fractions and other radiobiological metrics 
to quantify dose enhancement, measurement of ROS production in aqueous environments in 
vitro is a common and facile quantitative method to indicate enhancement. This also allows for 
the investigation of the production of ROS and specific ROS that are responsible for any 
observed radioenhancement. However, the short lifetime of HO· and the previous lack of 
sensitive assays have made the quantification technique of the specific free radical difficult. 
While the radical alone is not intensely useful for measurement, HO· will hydroxylate organic 
aromatic rings and these derivatives can be highly fluorescent[10]. Therefore this fluorescence is 
proportional to the amount of HO· set forth post-irradiation. These functional  groups include 
benzoates, coumarins, and phenoxazines[10]. Coumarins are a category of photochemicals that 
have previously been used in multiple studies to detect HO· levels following radiation[21]. The 
coumarin HO· trapping assay is highly sensitive and is able to detect minimal concentrations of 
hydroxyl radicals, down to 30nM. This technique identified the dependence of 7-
hydroxycoumarin (7OH) intensity on nanoparticle concentration, allowing the estimation of HO· 
production[9]. The fluorescent yield for 7-hydroxycoumarin-3-carboxylic acid via coumarin-3-
carboxylic acid is estimated to be 4.7% per HO· in the absence of any added scavengers[10]. 
Radical scavengers can include acetone, acetonitrile, methyl alcohol, and dimethyl sulfoxide 
(DMSO), which prevent hydroxylation at the seventh ring position to create 7-hydroxycoumarin-
3-carboxylic acid[10]. 
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Enhancement Modes 
 There are three main accepted modes of radiation enhancement in the presence of 
nanomaterial: physical, chemical, and biological enhancement. Each category is subdivided into 
the specific mechanisms which define the process which were previously ambiguous to 
researchers. Guo provides a comprehensive review of these mechanisms and clarifies many 
definitions[22]. For this project, physical and chemical enhancement are the most pertinent 
modes. 
Physical enhancement (PE) is defined as enhancement without the aid of chemical or 
biological processes, meaning energy transfer by non-catalytic reactions and without biological 
regulation[22]. The category can further be subdivided into Type 1 PE, Type 2 PE, and Type 3 
PE based on the energy transfer and deposition from the external radiation to the tissue. Despite 
the separation of deposition mechanisms, there are often multiple types of enhancement present 
and contributing to radiation enhancement. Type 1 PE (T1PE) is characterized by uniform 
enhancement and energy deposition through electron interactions stemming from the 
nanoparticles throughout a sample volume. Due to T1PE and T2PE often being present 
simultaneously, specifically with larger nanoparticles, T1PE will dominate and account for the 
majority of enhancement. However, difficulties defining this mechanism are present. The 
presence of chemical enhancement and anti-enhancement can appear when T1PE is large. This 
also is dependent upon the probe being uniformly distributed over the entire volume.  
Type 2 PE (T2PE) is seen near the surface of nanomaterial, instead of uniformly through the 
volume as in T1PE. The enhancement present is dependent upon the size and shape of the 
nanoparticles and is derived from particularly low energy electrons depositing their energy in 
close proximity to the nanomaterial surface. This enhancement is also difficult to characterize 
due to the placement of the probe. If uniformly distributed, the probe will most likely see T1PE 
but if placed near the surface of the nanomaterial, increased T2PE will be detected.  
Type 3 PE (T3PE) can be further bifurcated into two specific types: T3PE(1) and T3PE(2). 
T3PE(1) is the most common between the two and results in the emission of UV-VIS photons 
from the X-rays being absorbed in the nanomaterial and the subsequent electrons transfer energy 
to the semiconductor/rare earth material. T3PE(2) results from the X-ray energy being absorbed 
by the medium and subsequent electrons originating from outside the material excite the 
semiconductor/rare earth and produce the photons. Materials of a low atomic number are more 
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likely to cause T3PE(2) due to electron-hole pairs being created in the medium because the 
nanomaterial has a lower affinity to absorb the x-ray energy.  
Discrepancies in predictive models (Monte-Carlo based) for dose enhancement and 
experimental results indicated that physical enhancement could not be solely responsible for the 
observed enhancements[23]. Chemical and biological enhancement mechanisms have also been 
proposed. Chemical enhancement examines the role of the nanomaterial in the chemical 
reactions that occur in the environment post-irradiation. Well-characterized materials that have 
been previously investigated for the composition of nanoparticles include silver, gold, platinum, 
silica, and more[24]. The selection of these materials included a key characteristic of being 
unreactive and chemically inert. However, this is no longer a valid assumption due to 
unaccounted for enhancement and now must be reviewed as a catalyst.  In the review by Guo, 
chemical enhancement is segmented into type 1 (T1CE) and type 2 chemical enhancement 
(T2CE). The difference between the two relies primarily on whether there is an increased 
production of ROS present. T1CE reports no significant increase in ROS but rather enhancement 
due to the catalytically active surface of the nanoparticle. This can also include catalysis of DNA 
strand break reactions and polymerization[23]. T2CE does report increased ROS production but 
attributes this as a catalytic increase due to the nanomaterial chemically reacting with the 
environment. Also identified as a dynamic chemical enhancement, it requires the activation of 
the nanomaterials by superoxides generated from radiation while PE requires increased 
absorption by the nanomaterial to produce the radical groups under irradiation[23].  
Biological enhancement is the result of electrons from the surface of nanomaterial interacting 
with an aqueous environment to produce ROS whose DNA damage effects have been previously 
mentioned. However, biological enhancement is seen with or without the use of ionizing 
radiation and solely in the presence of nanomaterial to send cells into oxidative stress and 
damage primary targets such as the mitochondria and induce cytotoxicity. Evidence of cell cycle 
effects distributing cells into radiosensitive phases such as G1/M or disrupting cell cycle 
checkpoints in the presence of GNP and other materials have been reported. The bystander and 
abscopal effects have also been considered due to the influence nanomaterial can have on cell to 
cell communication and influence production of intercellular signals such as ROS and cytokines. 
This could, therefore, affect cells that have not been directly exposed to radiation and warrant a 
response outside the affected region[25]. 
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Enhancement Units 
 To quantify enhancement, metrics have been created and used in the literature to allow 
quantitative analysis of results. Dose enhancement can be quantified by dose enhancements 
units, DEUs[22][23]. An important distinction to note is whether the DEUs are relative or 
absolute values. DEU is calculated by using the ratio of measured signal with nanomaterial to 
that without nanomaterial. It is vital to consider the ROS production of the irradiated material, 
coumarin-3-carboxylic acid, without nanomaterial present in order to establish enhancement 
when present. This calculation would be a relative value, while this value minus one is an 
absolute DEU[22]. For this project, the fluorescence signal measured of the 7-hydroxycoumarin-
3-carboxylic acid (7-OH-CCA) will be the benchmark of enhancement. These calculations are 
demonstrated in Equations 1 and 2. Specific to radiation oncology and therapeutic applications, 
dose enhancement ratios (DER) are also quoted in the literature.  
 
 (1)																																																				𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒	𝐷𝐸𝑈 = 01231445	6789	:;01231445	6789<=8	:;  
 (2)																																											𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒	𝐷𝐸𝑈 = 01231445	6789	:;01231445	6789<=8	:; − 1  
 
 Another metric has been proposed recently in addition to DER and bridge the gap of 
discrepancies between radiobiological results and theoretical predictions. Linear energy transport 
enhancement ratio (LETER) has been addressed by Gadoue and Toomeh for the first time via the 
radiation transport code SCEPTRE[26]. The equation for LETER can be seen in Equation 3. The 
motivation for introducing investigation into linear energy transfer (LET) stemmed from the 
metric’s association with biological effects. As more energy is lost per unit distance of the 
secondary charged particles track, more and densely packed ionization events can occur along 
the path and therefore can induce significant biological damage in the immediate spatial area. 
Previous studies have demonstrated increases in LET of secondary electrons near GNPs as well 
as at the nanomaterial and soft tissue interfaces. This new metric could be more effective in 
associating radiobiological consequences and predicting outcomes based on the parameters 
selected. During Gadoue and Toomeh’s simulations, they were able to demonstrate a lower 
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LETER than DER at 120kVp with both 50nm and 100nm GNP. Using 100nm GNP, however, 
LETER decreased even more so than with the 50nm simulation, most likely due to self-
absorption of low energy secondary electrons. At 6MV energy, they were able to demonstrate 
higher LETER values than DER which increased with larger GNPs. While more investigation 
into using this metric is needed, this theory could account for previous discrepancies in 
experimental results.  
 (3)							𝐿𝐸𝑇𝐸𝑅 = 𝐴𝑣𝑒𝑟𝑎𝑔𝑒	𝐿𝐸𝑇	𝑑𝑢𝑒	𝑡𝑜	𝑠𝑒𝑐𝑜𝑛𝑑𝑎𝑟𝑦	𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠	𝑖𝑛	𝑡ℎ𝑒	𝑝𝑟𝑒𝑠𝑒𝑛𝑐𝑒	𝑜𝑓	𝐺𝑁𝑃𝐴𝑣𝑒𝑟𝑎𝑔𝑒	𝐿𝐸𝑇	𝑑𝑢𝑒	𝑡𝑜	𝑠𝑒𝑐𝑜𝑛𝑑𝑎𝑟𝑦	𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠	𝑤𝑖𝑡ℎ𝑜𝑢𝑡	𝐺𝑁𝑃  
 
III. Objectives 
To synthesize and characterize nanoparticles composed of high atomic number elements and 
semiconductor material in a core/shell structure for the potential to be used as sensitizers for 
radiotherapy as well as in luminescence imaging platforms. Additionally, we sought to quantify 
their role in free radical production after exposure to ionizing radiation through chemical routes 
to investigate their role in radioenhancement. 
 
IV. Methods  
The synthesis of the core/shell nanoparticle required a variety of protocols and 
characterization at progressive stages of completion. The gold cores were synthesized first and 
then characterized to allow for adjustment and an analysis of size control. Once the core samples 
were prepared, they were then characterized by a variety of techniques as described later in this 
section. After the completion of the gold cores (AuNPs), the spherical nanoparticles of both 
diameters were used separately to create the europium-doped gadolinium vanadate flower-like 
nanoparticles (Au/GdVO4:Eu NPs). These final product nanoparticles were then characterized 
and compared to the synthesis protocol for analysis. After confirmation of the composition and 
geometry of both AuNPs and Au/GdVO4:Eu NPs, irradiation protocols were followed as well as 
measurement techniques. Each of these steps will be described in the following section.  
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Gold Nanoparticle Core Synthesis 
Two diameters were selected for the spherical gold nanoparticles that would serve as the 
core for the flower-like nanoparticle. Synthesis protocols for diameters of 12 nm and 25 nm were 
carefully chosen to explore the size dependence of the radiation enhancement on the amount of 
gold present in the sample, as well as a different basis for building the luminescent shells. 
Turkevich et al. established the underlying protocol for the synthesis of colloidal gold and the 
method for size control via citrate stabilization [27]. While the nucleation and growth processes 
are constant, different heating times, concentrations, and chemical amounts are varied to control 
the diameters of the spherical nanoparticles. Sodium citrate and gold chloride are the chemical 
basis for both these synthesis methods. It should be noted here that each sample underwent 
cleaning cycles before imaging and irradiation. This cleaning technique involves centrifuging the 
samples to induce precipitation of the particles and removing the supernatant. The exact volume 
extracted was then replaced with water. This is a mandatory step in the preparation process due 
to the influence the chemicals, primarily sodium citrate, could have on the characterization 
techniques as well as its potential to act as a radical scavenger therein reducing the presence of 
hydroxyl radicals and reducing fluorescence measurement[28].  
12nm Gold Nanoparticle Core Synthesis Method 
50 mL of 1mM hydrogen tetrachloroaurate was added to a 100 mL volumetric flask with 
stopper. The solution was brought to 80° C on a hot plate with vigorous magnetic stirring. Once 
at 80° C 0.2 mL of 1 M trisodium citrate was added to the solution. The solution was then 
maintained at 80° C with stirring for 25 minutes with temperature checks every 3-5 minutes with 
a thermometer.  The red wine color solution was cooled to room temperature and stored with 
limited light exposure [27]. The concentration of gold within each sample of the solution was 
0.23 g/L.  
 
25nm Gold Nanoparticle Core Synthesis Method 
135 𝝻L of 0.1M trisodium citrate was added to 50 mL of ultrapure water in a 100 mL 
volumetric flask with stopper. The solution was brought to 80°C on a hot plate with vigorous 
magnetic stirring. Once at 80°C, 250 𝝻L of 50mM hydrogen tetrachloroaurate was added to the 
solution. 
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The solution was then maintained at 80°C with stirring for 25 minutes with temperature 
checks every 3-5 minutes with a thermometer. The solution was cooled to room temperature and 
stored with limited light exposure [11]. The concentration of gold within each sample of the 
solution was 0.057 g/L. In order to maintain a consistent concentration of gold between the two 
sizes of gold nanoparticles in the measured samples, these larger particles were centrifuged 
(10000 rpm for 10 minutes) and underwent volume reduction (50.385 mL to 12.551 mL) to raise 
the concentration to that of the smaller gold nanoparticles, 0.23 g/L.  
 
 
 
Figure 1.) Gold nanoparticles in solution after synthesis 
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Au/GdVO4:Eu Core/Shell Nanoparticle Synthesis 
 A facile protocol was selected using sodium citrate as a stabilizer for the gold 
nanoparticle cores, but also as a linker/chelating agent, stabilizer, and soft template for the 
shell[11]. The citrate’s role in the process allows for full nucleation onto the core and growth of 
the heterogeneous structure.  
0.6 mL of 0.1 M trisodium citrate was added to 10 mL of the gold nanoparticle solution, 
as prepared above, under magnetic stirring. 200 𝝻L of 0.01 M Gd(NO3)3 aqueous solution 
containing 5% Eu(NO3)3 and 100 𝝻L of 0.1 M Na3VO4 was injected into the former solution. 
The solution was then transferred to the 20 mL Teflon bottle for placement inside the stainless 
steel pressure vessel. The solution was then sealed and maintained in the oven at 200°C for two 
hours. The vessel was then left to cool to room temperature until centrifugation. The solution 
was then transferred to a centrifugation vial and centrifuged at 8000 rpm for 8 minutes 
(Eppendorf Centrifuge 5804 R). The nanoparticle solution was then cleaned by removing 
supernatant containing surfactant residues and replacing it with purified water [11]. A schematic 
of this process can be seen in Figure 2. These nanoparticles in solution were also seen to have a 
bright red emission under UV irradiation as can be seen in Figure 3.  
 
Figure 2.) Schematic of Au/GdVO4:Eu synthesis via extended heating in a pressurized vessel.  
Synthesized Au NPs
 Sodium Citrate
Gd(NO3)3
with 5% Eu(NO3)3
Na3VO4
 mixed using  
vigorous 
magnetic stirring
Teflon 
bottle
filled 
with 
sample
placed in oven
200 C
120 min
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Figure 3.) Au/GdVO4:Eu bright red luminescence property under UV irradiation.  
 
 
Characterization Techniques  
Two techniques were employed to characterize both the spherical cores and flower-like 
nanoparticles. These techniques were scanning transmission electron microscopy (STEM) and 
UV-VIS spectroscopy. 
 
i. Scanning Electron Microscopy (SEM) 
Images of the gold cores and synthesized core/shells were obtained by using STEM. This 
was a visual confirmation of the geometrical configuration of both the spherical cores and 
flower-like structural shells. Software, ImageJ, was also utilized to also verify the size of the 
synthesized particles and obtain particle size distributions data that is listed in the Results 
section of this work. This software uses the SEM images to set the scale and allow for 
accurate measurements of each individual particle diameter. Approximately 500 nanoparticle 
measurements were used to create the distributions.  
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ii. Ultraviolet-Visible Spectroscopy (UV-VIS) 
UV-VIS spectroscopy with a Thermo Scientific Genesys 10S UV-Vis Spectrophotometer 
(Waltham, MA) was performed on the core and core/shell nanomaterials to identify the 
absorption peaks and analyze the constituent material. This was performed firstly on the gold 
nanospheres alone and then when the shells were created deposited to examine the changes in 
optical properties.  
 
 
Quantification Technique 
 
i. Coumarin-3-carboxylic acid 
Alfa Aesar (Portland, OR) coumarin-3-carboxylic acid 98% was purchased and utilized 
for this experimental protocol. Solutions at concentrations of 1mM and 2mM, were selected 
to be combined with nanoparticle suspension in order to compare the differences in hydroxyl 
radical production when the concentration of nanoparticles present varied. Therein, the 
concentration of the coumarin-3-carboxylic acid would be kept constant at 0.5mM in all 
irradiation experiments and not influence the hydroxyl radical production. A separate 
solution at a concentration of 0.5mM was made and irradiated without nanoparticles to 
establish a baseline measurement for enhancement.  
 
ii. 7-hydroxycoumarin-3-carboxylic acid 
7-hydroxycoumarin-3-carboxylic acid was selected to be the fluorescent derivative of 
interest in irradiated coumarin-3-carboxylic acid that would be the focus of this 
quantification. According to manufacturing information provided as well as findings by 
Nafradi et al, the excitation wavelength was determined to be 342nm and the maximum 
emission wavelength was 447nm[21]. Due to the light sensitivity of the material and 
dependency on environmental conditions, the chemical was stored in the freezer when not in 
use.  TCI AMERICA (Boston, MA) 7-hydroxycoumarin-3-carboxylic Acid 98% was utilized 
for this calibration curve. The calibration curve of various prepared concentrations of 7-
hydroxycoumarin-3-carboxylic acid allow an association to be made between the amount of 
the fluorescent derivative present (associated with the amount of HO• present) and the 
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measured fluorescence intensity. A sample of 7-hydroxycoumarin-3-carboxylic acid under 
UV irradiation can be seen in Figure 4. 
 
 
Figure 4.) Sample of 7-hydroxycoumarin-3-carboxylic acid fluorescence. 
 
iii. Fluorescence Detection  
An Ocean Optics Flame VIS-NIR Fluorescence Miniature Spectrometer was used as the 
apparatus to measure the fluorescence intensities of the samples. A deuterium lamp was the 
light source used for this measurement. Associated accessories to the experimental setup 
such as two Ocean Optics fiber optic cables, four-sided quartz cuvette with 1cm path length 
(ThorLabs, Newton, NJ), and cuvette housing with covering (to prevent detector saturation) 
was utilized. This experimental setup is pictured below in Figure 5. In addition to the 
consistent setup of the apparatus, the associated Ocean Optics software Ocean View 1.67 was 
utilized for analysis. The analysis procedure was kept consistent across every fluorescence 
measurement to increase the sensitivity of the signal and obtain a desirable fluorescence 
spectrum. The protocol selected was 10 scans averaged together each lasting 5 seconds with 
a boxcar width of 10 to appropriately smooth the spectrum and average adjacent points 
without reducing the spectral resolution significantly. This resulted in the measurement cycle 
lasting 50 seconds each. A background scan was recorded before each measurement session 
with a sample in the cuvette holder to be able to remove ambient signals from the 
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measurements. If the recorded spectrum was found to be noisy or with unexpected peaks, an 
additional background scan was recorded to remove the influence of signals such as detector 
saturation or light leakage. It should be noted that there was a consistent signal found to be at 
450nm in all data recorded with the spectrometer. It was determined to be a defect within the 
equipment and this was cautiously considered in spectral analysis.  
   
 
  
Figure 5: A) Experimental setup for fluorescence measurement. B)* 90° placement of fibre 
optic cable for measurement. *Adapted from Ocean Optics.  
 
iv. 7-Hydroxycoumarin-3-carboxylic acid calibration curve 
To establish the fluorescence intensity associated with the measurement of irradiated 
coumarin-3-carboxylic acid and therefore 7-hydroxycoumarin-3-carboxylic acid (the 
fluorescent derivative), varying concentrations of 7-hydroxycoumarin-3-carboxylic acid were 
prepared and measured. Various concentrations ranging from 0.1-4 µM were calculated, 
prepared, and measured with the previously mentioned apparatus. These concentrations were 
selected for two reasons. One, they were reasonable predictions of the concentration of 7-
hydroxycoumarin-3-carboxylic acid after irradiation. Second, to establish a well-defined 
A
. 
B
.. 
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calibration curve over a wide range of concentrations and analyze the accuracy of the counts 
obtained from the detector at each concentration. Serial dilution was performed in order to 
obtain the various concentrations while economically preserving the material. Each 
concentration was prepared three times to establish reproducibility and obtain a standard 
deviation for the counts of each sample. The three replicates were averaged and used for the 
calibration curve values at the maximum emission wavelength (~447nm)[4]. Note, these 
concentrations were prepared with ethyl alcohol 95% (Fisher Science Education) for better 
solubility and uniform distribution of the solid chemical. Newton and Milligan previously 
investigated the role of radical scavengers on the detection of fluorescent product yields to 
confirm that the hydroxyl radical is responsible for the formation of the fluorescent 
derivatives after irradiation[10].  
 
 
Sample Preparation for Irradiation 
A Precision X-Ray X-Rad 225 XL irradiator was utilized to deliver varying doses to the 
prepared samples using ionizing x-rays. No collimation or filtering was used when delivering the 
treatment. Doses of 50, 100, 150, and 200 Gray were delivered to the samples to establish a dose 
dependence and compare to previous literature results. The irradiation protocol was set for 225 
keV, 13.3 mAs, and an SSD of 12cm. The dose rate of 12,762 cGy/min as provided by the 
manufacturer made for irradiation times of 24, 48, 72, and 96 seconds for doses of 50, 100, 150, 
and 200 Gy respectively. This device can be seen in Figure 6.  
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Figure 6.) The X-RAD 225 XL irradiator used for the experimental procedures.  
 
Irradiation Protocol 
In order to investigate the radiation enhancement in aqueous environment in the presence of the 
manufactured nanoparticles and establish them as radiosensitizers, the irradiation protocol was 
performed on multiple materials. These materials included the following: 
1. 0.5mM 3-coumarin-carboxylic acid without nanoparticles 
2. 1.5mL of 1mM 3-coumarin-carboxylic acid with 1.5mL of 25nm gold cores 
3. 0.75mL of 2mM 3-coumarin-carboxylic acid with 2.25 mL of 25nm gold cores 
4. 1.5mL of 1mM 3-coumarin-carboxylic acid with 1.5mL of 12 nm Au/GdVO4:Eu 
core/shell nanoparticles 
5. 1.5mL of 1mM 3-coumarin-carboxylic acid with 1.5mL of 25 nm Au/GdVO4:Eu 
core/shell nanoparticles 
6. 0.75mL of 2mM 3-coumarin-carboxylic acid with 2.25mL of 12 nm Au/GdVO4:Eu 
core/shell nanoparticles  
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7. 0.75mL of 2mM 3-coumarin-carboxylic acid with 2.25mL of 25 nm Au/GdVO4:Eu 
core/shell nanoparticles 
 
i. Gold nanoparticle irradiation 
Irradiation of the gold cores was performed to establish the role of the high atomic 
material within the sample if radiosensitization was to be induced. Additionally, this data would 
be compared to the irradiation of the full core/shell nanoparticle synthesized to investigate the 
performance of the shell, when introducing new elements and geometry, in the presence of 
ionizing radiation. An important step that will be seen in both the core and core/shell 
fluorescence measurement will be the removal of the nanomaterial prior to the fluorescence 
spectra being recorded. It has been observed that increased incubation times of the nanomaterial 
with the oxidized coumarin results in decreased fluorescence intensities, with the signal decrease 
being exacerbated at higher doses[9]. This supports protocols with short irradiation times and 
swift removal of supernatant for measurement for more accurate data collection.  
1.5mL of 25nm spherical gold nanoparticles, at the concentration provided in the 
manufacturing procedure, was injected with 1.5mL of 1mM coumarin-3-carboxlic acid. This 
would produce a AuNP concentration of 0.55mM. The sample was prepared in a small acrylic 
container to be placed in the irradiator.  This same container was used consistently for all 
irradiations, with appropriate cleaning in between. The presence of 7-hydroxycoumarin-3-
carboxylic-acid was then measured using the fluorescence apparatus as described above for each 
dose administered. To avoid quenching of the fluorescence signal as a function of contact time 
between the nanoparticles and hydroxylated coumarin, the sample was centrifuged at 10,000 rpm 
for 3 minutes with intermediate acceleration and deceleration settings[9]. The supernatant liquid 
removed was then placed in the fluorescence spectrometer, therefore removing the nanoparticles 
from the solution.  
Then, 2.25mL of spherical gold nanoparticles, of either size, was injected with 0.75mL 
2mM coumarin-3-carboxylic acid. This would produce a AuNP concentration of 0.825mM. The 
same irradiation protocol and measurement technique was used to measure these samples. This 
was done to investigate the production of 7-hydroxycoumarin-3-carboxylic acid in the presence 
of different amounts of gold and with different concentrations of coumarin-3-carboxylic acid.  
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It should be noted that due to the nature of the 12 nm AuNPs, cleaning was not readily 
achievable via centrifugation. Extensive amounts of centrifugal force and time would be required 
to clean these very small particles. The 12nm AuNPs were not irradiated without shells due to 
the presence of sodium citrate and observed signal quenching. However, they were still utilized 
in the shell synthesis. 
 
 
ii. Core/shell nanoparticle irradiation 
A very similar irradiation protocol to the gold core irradiation was followed for the core/shell 
nanoparticles. Two amounts of the nanoparticle solution were selected to be irradiated to 
investigate hydroxyl radical production in the presence of various amounts of nanomaterial. 
However, once again the coumarin-3-carboxylic-acid would be maintained at 0.5mM using 
various amounts of nanomaterial solution with 1mM and 2mM prepared coumarin-3-carboxylic 
acid. The original concentration of nanoparticle solution was calculated to be 0.184 mM of 
GdVO4. Once again 1.5mL NPs were combined with 1mM 3-CCA for irradiation. Centrifugation 
of 10,000rpm for 2 minutes at maximum acceleration and deceleration settings was utilized to 
prevent signal quenching.  When combined with 3-CCA, the concentrations of GdVO4 in 
solution were calculated to be 0.092 mM and 0.138 mM. 
 
 
V. Results 
 
Morphological characterization of the 12nm AuNPs 
The 12nm AuNP cores were successfully synthesized via the stated method. However, as can 
be seen in Figure 7 A, the first trial of synthesis, performed at a temperature of 90°C for 15 
minutes, resulted in larger particles and variability in size than anticipated. According to the 
literature and the original work of Turkevich et al. ,[27], the synthesis temperature and heating 
time plays an important role in the final characteristics of the product. Therefore, the synthesis 
procedure was optimized after consulting by reducing the synthesis temperature to 80°C and 
increasing the time to 25 minutes. As seen in Figure 7 B, C, D, the resulting particles in the 
following trials were approximately 12nm in diameter with a reasonable standard deviation 
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~10%. These size distributions were obtained with the software ImageJ measuring the individual 
particles in the STEM images of each sample, with an average of 500 particles measured per 
distribution.  
 
 
 
Figure 7.) Particle size distribution of synthesized 12nm gold cores. A) Run #1 19.2 ± 3.16 nm* 
B) Run #2 12.4 ±1.58 nm C) Run #3 12.7 ± 1.41 nm  D) Run #4 11.9 ± 1.22 nm. *Change in 
protocol after Figure 7A to achieve improved size control in Figure 7B-D. 
 
 
 
 
 
A. B. 
C. D. 
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Morphological characterization of the 25nm AuNPs 
The synthesis protocol for the 25nm AuNPs was also considered successful and 
reproducible. Figure 8 shows the size distribution of the synthesized particles once again roughly 
measuring 25nm with a ~10% standard deviation.  
 
 
 
Figure 8.) Particle size distribution of synthesized 25nm gold cores. A) Run #1 23.4 ± 2.34 nm 
B) Run #2 24.8 ±2.48 nm C) Run #3 26.5 ± 2.78 nm  
 
 
 
A. B. 
C. 
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STEM 
STEM images are displayed in Figure 9. A multitude of these images were used to obtain the 
size distributions above. This also allowed for a visual confirmation of spherical and core/shell 
geometries. The Au/GdVO4:Eu as seen in Figure 9C visualizes the gold spherical core seen in 
the center of the associated shell and confirms the foundation of the shell being centered around 
the Au NP.  
 
 
 
Figure 9.) STEM images obtained with Ultra High-Resolution Analytical FE-SEM SU-70 of 
A) 12nm gold cores B) 25nm cores C) Au/GdVO4:Eu NPs 
 
A. B. 
C. 
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UV-VIS 
Two main peaks were identified for each of the synthesized materials. A peak around 
~274nm is present due to the sodium orthovanadate within the sample. The second peak is 
surface plasmon resonance peak observed in gold nanoparticles, and it is dependent on their 
sizes. The peaks seen in Figure 10A at 520nm and Figure 10B at 527nm for 12nm and 25nm 
gold cores respectively are within the correct range for absorption peaks for those sizes. The 
other peak seen is the result of absorption spectra of the Au/GdVO4:Eu nanoparticles. According 
to the synthesis protocol, red-shifting of this peak from 542nm to 562nm was observed at 0.5 
hours of heating versus 12 hours of heating respectively[11]. However, our results reveal that 
instead of red-shifting, peak broadening can be observed.  Due to this, a heating time of two 
hours was selected due to evidence that the shell was present and fully formed with sufficient 
thickness by that point.   
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Figure 10.) Absorption spectra of Au/GdVO4:Eu nanoparticles with various sizes of Au cores 
and the effect of heating times A.) 12nm cores B.) 25nm cores 
 
 
7-Hydroxycoumarin-3-Carboxylic Acid (7-OH-CCA) Calibration Curve  
 The curve seen in Figure 11 corresponds to the calibration curve for different 
concentrations of 7-OH-CCA and their associated fluorescence intensities at ~447nm. Three 
solutions of each concentration ranging from 0.1-4µM were prepared and placed in the quartz 
cuvette for fluorescence measurement. The same quartz cuvettes with 1 cm path length would be 
used to measure the irradiated samples. As expected, a strong linear correlation is seen between 
the concentration and the respective fluorescence intensity, resulting in a coefficient of 
determination of 0.9991 of the linear fitting. The obtained equation of y=469x+13.2 would allow 
for 7-OH-CCA estimations to be made in irradiated samples and therefore comparatively 
measure the amount of OH radicals present.  
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Figure 11.) 7-Hydroxycoumarin-3-carboxylic acid calibration curve  
 
 
0.5mM Coumarin-3-Carboxylic Acid (3-CCA) Irradiated without nanomaterial 
 A concentration of 0.5mM 3-CCA was irradiated with no nanomaterial in the sample to 
establish a comparison when no nanomaterial was present. This would be the concentration of 3-
CCA in all samples, including those with nanomaterial due to the dilution of the solution from 
the nanomaterial being dispersed in water. Fluorescence intensities were measured at 
approximately 125, 175, 250, 300, and 350 counts for 0, 50, 100, 150, and 200 Gy respectively. 
A linear fit of the data revealed a coefficient of determination of 0.9935 and fitted equation of 
y=1.16x+127, maintaining a linear relationship without nanomaterial present. For the 
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representation of the data in Figure 12, the data has been normalized to the intensity acquired at 0 
Gy. This configuration will continue for the remaining figures.  
 
 
 
Figure 12.) Fluorescence measurement of 7-OH-CCA of 0.5mM coumarin-3-carboxylic acid 
irradiated with no nanoparticles. 
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25nm AuNPs and 3-CCA Irradiated  
 25nm AuNPs were irradiated using two different concentrations to demonstrate an 
enhancement of hydroxyl radical production and increased amount of 7-hydroxycoumarin-3-
carboxylic acid. These two normalized data schemes can be seen in Figure 13 and are compared 
to the data collected when no nanomaterial was present.  
 
 
Figure 13.) Fluorescence measurement of 7-OH-CCA of coumarin-3-carboxylic acid irradiated 
with two varying concentration of 25nm AuNPs, compared to irradiation with no nanoparticles.  
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Au/GdVO4:Eu NPs with 25nm Au cores and 3-CCA Irradiated  
 The data for the 25nm AuNPs at two differing concentrations are compared for the 
fluorescence measurements when the shell was added to the core. Once again these values are 
measured at the intensity of 447 nm.  
 
 
Figure 14.) Comparison fluorescence measurements of 7-OH-CCA in 25nm AuNP irradiated and 
(25nm)Au/GdVO4:Eu NPs irradiated.  
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Au/GdVO4:Eu NPs with 12nm Au cores and 3-CCA Irradiated  
 The fluorescence measurements recorded for the Au/GdVO4:Eu NPs synthesized with the 
smaller 12 nm cores indicate a mild increase in the fluorescence intensity at higher 
concentrations. However, as can be seen in Figure 15, most error bars are overlapping except for 
at a dose of 150 Gy. The intensity at 447 nm is increased slightly for most doses from the lower 
concentration. Although, as stated, the variation of the measurements is large in this set and must 
be taken into account.  
 
 
Figure 15.) Fluorescence measurement of 7-OH-CCA of coumarin-3-carboxylic acid irradiated 
with two varying concentrations of Au/GdVO4:Eu NPs synthesized with 12nm AuNP cores.  
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7-OH-CCA Estimation 
 Given the fitted curve for 7-hydroxycoumarin-3-carboxylic acid as obtained and 
displayed in Figure 11, the equation of y=459x+13.2 was used to estimate the amount of 7-OH-
CCA in the samples post irradiation. These are listed in Table I. It should be noted here that the 
raw data was used for these calculations, not taking into account the quenching effects of the 
signal.  
 
 7-OH-CCA Estimation (µM) 
Dose 
(Gy) 
No NP 0.55mM 
25nm 
AuNPs 
0.83mM 
25nm 
AuNPs 
0.55mM 
Au 12nm 
cores + 
0.09mM 
GdVO4 
0.83mM 
Au 12nm 
cores + 
0.14mM 
GdVO4 
0.55mM 
Au 25nm 
cores + 
0.09mM 
GdVO4 
0.83mM 
Au 25nm 
cores + 
0.14mM 
GdVO4 
0 0.25 0.15 0.075 0 0 0.0060 0.012 
50 0.35 0.24 0.28 0.082 0.0098 0.23 0.084 
100 0.52 0.31 0.44 0.14 0.16 0.45 0.12 
150 0.63 0.42 0.53 0.14 0.22 0.53 0.23 
200 0.74 0.48 0.66 0.25 0.29 0.59 0.23 
 
Table I. 7-hydroxycoumarin-3-carboxylic acid estimations within samples following 
irradiation.  
 
These calculated values seen in Table I bring insight to the amount of 7-hydroxycoumarin-3-
carboxylic acid present in the sample immediately following irradiation. This therefore gives an 
indication of the hydroxyl radical production and whether that has increased in the presence of 
nanomaterial. Previous groups have reported the fluorescence yield of 7-hydroxycoumarin-3-
carboxylic acid to be approximately 3-5%[9][10]. For example, if a 4% yield is found, then for 
every 100 hydroxyl radicals set forth, 4 will hydroxylate the coumarin-3-carboxylic acid to 
produce the fluorescent product of 7-hydroxycoumarin-3-carboxylic acid.  
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Figure 16.) Comparison of estimations of 7-OH-CCA present in samples post-irradiation. 
 
VI. Discussion 
 
25nm AuNPs and 3-CCA Irradiated  
The molarity of gold within the samples of 25nm AuNPs was calculated to be 1.1mM. When 
diluted for irradiation with coumarin-3-carboxylic acid the molarity of gold was reduced to 
0.55mM and 0.83mM in the different samples. As previously stated, the diluted concentration of 
coumarin-3-carboxylic acid was kept to 0.5mM. Figure 13 shows the fluorescence measurements 
at the emission wavelength 447 nm for each sample irradiated. It was observed that the lower 
concentration of nanoparticle solution was below the sample irradiated with no nanoparticles, 
even at 0 Gy, indicating a quenching of the signal even without irradiation. However, this 
0 20 40 60 80 100 120 140 160 180 200
Dose (Gy)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
7-
OH
-C
CA
 co
nc
en
tra
tio
n 
(
M
)
7-OH-CCA Production Estimation
0.55mM 25nm AuNPs
0.84mM 25nm AuNPs
0.55mM Au 12nm cores + 0.09mM GdVO4
0.83mM Au 12nm cores + 0.14mM GdVO4
0.55mM Au 25nm cores + 0.09mM GdVO4
0.83mM Au 25nm cores + 0.14mM GdVO4
 42 
 
reduction in counts may be due to the extended contact time between the nanoparticles and 
oxidized coumarin. As stated previously, quenching of measured fluorescence is observed due to 
the interruption of energy transfer in the presence of nanoparticles. Sicard-Roselli et al. observed 
signal reduction ranging approximately 10-30% after 16 minutes incubation time depending on 
dose delivered. A larger decrease was observed at higher doses, of 160 Gy as compared to 80 Gy 
and 120 Gy[9]. Due to the nature of our irradiation protocol and physical spatial locations of 
equipment laboratory, our contact time of nanoparticles with the oxidized coumarin was 
approximately five minutes. The longest irradiation time was 96 seconds, however, 3 minutes of 
centrifugation was also needed for these particles. Based on this literature and our irradiation 
protocol, the quenching of the fluorescence signal recorded could be nearly 20%.  
However, when comparing the normalized values of the gold concentrations, it can be seen 
that the higher concentration of gold nanoparticles caused increased fluorescence. This result 
compares to data in the literature where increased concentrations of the nanomaterial, 
specifically gold, leads to increased radiosensitization and production of ROS[9]. Sicard-Rosseli 
et al. used concentrations of 0.5 mM and 2 mM under 20 keV irradiation to demonstrate a 
respective ~120% increase in the linear fitting of 7-hydroxycoumarin-3-carboxylic acid 
production.  Our results support the evidence for increased 7-OH-CCA production at higher 
concentrations, even at a different irradiation energy. It is noted that a decrease in fluorescence 
intensity is seen at the lower concentration of gold. This may be due to scavenging caused by 
residual sodium citrate or nanoparticles left in the solution, however when the concentration is 
raised enhancement is unbalancing the scavenging and allowing more intense fluorescence. 
Other considerations when applying this information to an in vivo study would be to consider the 
toxicity at high concentrations, clearance time of the material, and biocompatibility.  
 
Au/GdVO4:Eu NPs with 25nm Au cores and 3-CCA Irradiated  
 Figure 14 shows the data collected for both 25nm AuNPs and (25nm)Au/GdVO4:Eu 
irradiated. This comparison demonstrates the effect of the shell built onto the gold core. There 
are apparent differences between the less concentrated 0.55mM Au NPs and its equivalent 
sample with shells as well as the more concentrated samples. The intensity of the more 
concentrated core/shell sample is dramatically lower than the other core/shell sample. While the 
shell seems to provide enhancement at the lower concentration, it seems to decrease fluorescence 
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intensity at the higher concentration. This finding is significant because it allows conclusions to 
be drawn about the impact of material amounts on enhancement. This could even lead to a 
concept known as radioprotection.  
Radioprotection involves the inactivation of oxide molecules. Nanoparticles can act as 
mediators during redox reactions, specifically at electron transfer. Recombination as well as 
neutralization of ROS can occur in the immediate vicinity of nanoparticles, effectively 
suppressing the damaging effects of the oxide radicals. Orthovanadates and cerium dioxide 
nanorods have been investigated as radioprotectors and demonstrated their ability to protect 
tissues and cells from radiation injury[29]. It is important to note the differences in these 
materials in terms of geometry and composition. The addition of the GdVO4:Eu flower shell on 
the spherical gold core may be neutralizing more ROS produced due to the core itself and 
therefore reducing hydroxylation of the coumarin. This is specifically exhibited when higher 
concentrations of shell material are present. The addition of the gold core at lower concentrations 
may still allow for the interactions previously described to occur, even with the presence of the 
shell as to not scavenge the ROS. The production of ROS is likely higher than the scavenging 
rate of the shell. The lower concentration of the nanomaterial showing increased fluorescence in 
the presence of the shell may validate the material as enhancing at lower concentrations, and aid 
in identifying a threshold between the two effects. This concentration dependence has been 
published before by Hubenko et al., with less production of 7-hydroxucoumarin-3-carboxylic 
acid when more material was in the aqueous solution. Their work with GdVO4 :Eu3+ 
demonstrated, likely for the first time, the potential for vanadate based nanoparticles to be used 
as radioprotectors and act as scavengers for ROS, specifically hydroxyl radicals[30].  Previously, 
cerium oxide materials have been the subject matter for radioprotection.  
 When comparing the performance of the shells to each other, as represented by the 
dashed lines in Figure 14, there is significant reduction in the measured signal. We believe this 
corroborates the findings by Hubenko et al. and supports that with increasing concentrations of 
GdVO4 present in an irradiated sample, the neutralization of radicals can occur and therefore 
induce a radioprotectant effect. Despite the synthesized material in this project containing the 
material of gold at its core, which has established its dosimetric advantages, the orthovanadate 
present will shield those effects. While this was an unexpected finding of the project, its 
appearance is very useful and impactful for future endeavors.  
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Au/GdVO4:Eu NPs with 12nm Au cores and 3-CCA Irradiated  
 The performance of the Au/GdVO4:Eu NPs synthesized with 12 nm AuNP cores can be 
seen in Figure 15. There is a small enhancement that can be seen in the fluorescence 
measurements between the concentrations of the nanomaterial is irradiated. However, it is 
important to note the overlapping error bars for the majority of the doses administered. This 
indication of the measured values falling within the standard deviation for each dose makes it 
difficult to draw any solid conclusions from the data. Therefore evidence of radiosensitization 
nor radioprotection, also known as “anti-enhancement”, can be verified with this portion of the 
experiments.  
Due to the UV-VIS data collected, it is established that these core/shell particles are smaller 
than that of the core/shells when 25nm AuNPs were utilized. Figure 10 displays this data. Since 
the same concentrations and amounts of gadolinium nitrate and sodium orthovanadate were used 
in the shell synthesis despite core size, it can be hypothesized that the shell is thicker on the 12 
nm cores. Though these core/shells are not as large in diameter as those with 25 nm cores, the 
shell accounts for much of the size of the nanoparticle. Due to no significant changes being 
found in the irradiation data for these particles, one hypothesis could state that thicker shell 
formation does not contribute to radioprotection and rather it is concentration that is more 
significant. The crystalline structures of these shells is important to maintain and particularly this 
flower geometry could be further investigated to solidify its impact.  
 
7-OH-CCA Estimation 
The estimations of 7-OH-CCA can be found in Figure 16. In agreement with the literature 
and manufacturer specifications, the rise in concentration is correlated with the increase in dose 
administered. Not surprisingly, the highest concentration of AuNPs irradiated revealed the 
highest amount of 7-OH-CCA consistently amongst most doses, despite being slightly lower at 
100 Gy. The lowest production is from the samples of most concentrated (25nm)Au/GdVO4:Eu 
NPs and less concentrated (12nm)Au/GdVO4:Eu NPs. This corroborates the suspicion of the 
shell allowing less hydroxylation of the coumarin to form its fluorescent derivative.  
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VII. Future Work 
The introduction of nanomaterial into the medical field has been a work in progress for 
decades. However, multiple groups have demonstrated synthesis, measurement of 
radioenhancement, and feasibility in a number of irradiation schema and environments. Due to 
discrepancies and difficulties comparing previous studies, the transition has been very slow. Cui 
et al. has made recommendations for future preclinical and clinical trials involving AuNP-based 
radiosensitization. A standardization for future studies would aid in the clinical transition. 
Preclinical and in vitro study recommendations include thorough characterization and detailed 
reporting of physiochemical properties of the material (size, shape, coating, stability, etc.) to be 
able to correlate with various parameters when using cell lines. The cell lines chosen also allow 
investigation into the effect of  AuNP-based radiosensitization and DNA repair capacity and 
intrinsic radiosensitvity of the cell line. Considerations for clinical studies include small AuNPs 
for tumor penetration and distribution, surface coating for stability and uptake, administration 
routes, and locally advanced tumor types[1]. Nanoparticles of various elemental composition 
have even been suggested for image-guided external beam radiotherapy, internal radionuclide 
theranostics, and concomitant therapy with chemotherapy[5].  
 While many avenues could be taken to investigate multitudes of nanomaterial and 
enhancement of free radical production, a focus on the current material would be beneficial and 
allow further descriptions of its behaviors. Future work on the radiosensitization of 
Au/GdVO4:Eu NPs would include (i) irradiating the nanomaterial in the megavoltage range via a 
linear accelerator, (ii) explicitly exploring the behavior of the material in clinical CT and MRI 
settings, (iii) manipulating key characteristics of the NPs for advantageous gain, (iv) eventually 
placing the material in a cell line when deemed feasible and safe, (v) the use of different 
detection probes. Other characterization techniques could also be employed includes the use of 
transmission electron microscopy (TEM) to have a detailed visual of the material’s morphology.  
 
i. MV energy 
Placing the nanomaterial under clinically relevant energies and dose rates would be crucial in 
classifying Au/GdVO4:Eu NPs as a radiosensitizer, or seeing its converse effect as a 
radioprotector. Other contributing factors to the success of treatment plans would be 
fractionation schemes as well as administration routes and biodistribution. Previous studies 
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conducted under lower energies and dose rates, probably as a result of convenience and 
immediately available resources, was an important start to establishing nanomaterial’s potential. 
However, if the transition to clinic is ever going to occur then relevant data to radiation 
oncologists and medical personnel needs to be promising. The current experimental setup with 
using coumarin as a trapping assay would be problematic in the case of a linear accelerator. Due 
to the delay between placing the nanomaterial, opening and closing the vault door, and the need 
of fluorescence detection in close spatial proximity, signals measured would likely be very low 
due to extended times of nanomaterial contact. However, if using a cell line or animal model, 
survival fractions could be examined as well as survival rates post-irradiation. Other factors 
could be explored as well as Au/GdVO4:Eu NPs performance under delivery techniques like 
IMRT and SBRT as well as its performance on the image guidance system of a linear 
accelerator.  
 
ii. CT/MRI  
To establish the synthesized materials as multifunctional nanoparticles, other imaging 
besides luminescence platforms must be explored. The purposeful addition of dense, high atomic 
material for differential photoelectric absorption and enhanced contrast must be placed in a CT 
protocol and analyzed. Visual and Hounsfield unit (HU) analysis would be an additional 
characterization of the material. Changes such as silver cores instead of gold could also be 
possible to analyze a shift in image quality. Accumulation of the material could also be 
visualized in this manner and allow analysis of distribution within a vessel. The addition of 
gadolinium in the shell may allow for the material to be used as contrast agent for MRI. However 
investigation in the presence of magnetic field would be necessary to support this.  
 
iii. Nanomaterial 
The flexibility of synthesis and the variations available concerning nanomaterial make it a 
very adaptable process. Simple adjustments could create various geometries, compositions, sizes, 
thicknesses, etc. that could be investigated thoroughly. This has often been a source of difficulty 
when comparing studies due to their inherently different parameters. With the aid of 
characterization techniques to confirm key features, simple modifications in synthesis protocols 
could easily produce advantageous changes in the nanomaterial to be investigated further. These 
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could include elemental composition changes. For example, the bright red fluorescence of 
europium could be changed to terbium doping for a green emission. The size of the nanomaterial 
as well as the stability is also important considerations. Changes in core size and shell thickness 
could be investigated, but the stability of the material, including dissociation, would be crucial to 
explore. Additionally various concentrations of the material could be explored to record the 
effect of this on the radiosensitization or radioprotection effect. Whether this is for imaging or 
therapeutic purposes, the level of nanotoxicity should be regarded as an upper limit.  
 
iv. Cell lines 
The selection of cell lines and animal models is important transitional step to clinical 
transition and implementation. This proof of concept has been demonstrated using AuNPs 
previously and most commonly using rats as test subjects. Selection of radioresistant tumor cells 
could investigate the usefulness of this material in future trials to effectively improve the 
treatment of cancer that struggles to be contained effectively. Also this implementation would 
allow for further characterization of the material in a biological environment and how it behaves 
in vivo. A number of tools could be used to quantify the material’s effectiveness such as survival 
fraction and survival rates for various time periods. This would be one of the most important 
experimental sections to establish whether use in humans is viable.  
 
v. Different probes  
While the coumarin assay has been a useful and productive tool for the experiments 
performed, the method does have weaknesses that could be assisted by other techniques. The 
issues of signal quenching and poor fluorescence contributes uncertainty to the work. Other 
fluorescent products could be used with a higher yield to improve spectra. However, other 
investigative tools are available and have been used in the literature as a means of quantifying 
radiosensitization. Bacteria has been utilized as a benchmark for effective treatments. The 
removal of algal blooms like microcystis aeruginosa by irradiation has been reported[31]. If the 
implementation of nanoparticles could reveal a higher removal rate, this would be an effective 
quantitative finding. Other materials such as methylene blue have been reported to investigate 
the degradation and complexes with nanomaterial under irradiation[8][24][30].   
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This work has many promising directions and areas for opportunity for follow-up. A diligent 
and thorough examination of nanomaterial is needed to find agreement in the research 
community about the most effective material to synthesize and apply. Clinical transition is a 
daunting feat for this subject area and will require the collaboration of material scientists, 
engineers, radiobiologists, medical physicists, radiation oncologists, and many more. If 
accomplished, it would bring exciting advances to the world of theranostics. This project is a 
humble but essential beginning to accomplish viable options for testing in the future for 
Au/GdVO4:Eu nanoparticles. 
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